Best of ASTRO® 2024: Head & Neck Updates – Dr. Sarah Hamilton
OR
Chair
Dr. Paris-Ann Ingledew
Dr. Joanne Alfieri
Speaker
Dr. Sarah Hamilton
Studies/trials discussed:
- SBRT in 3 Fractions for T1 Glottic Cancer
- A Prospective Study Evaluating Sexual Health Outcomes in Patients Undergoing (Chemo)Radiation (CRT/RT) for Human Papillomavirus-Associated Oropharyngeal Cancer (HPVOPC)
- A Longitudinal Study Evaluating Sexual Health Outcomes and Prioritization in Patients Undergoing Chemoradiation for Human Papillomavirus-Associated Oropharyngeal Cancer
- Involved Site Radiotherapy in HPV Positive Oropharyngeal Cancer: Patterns of Failure Analysis Across Prospective De-Escalation Trials
- Optima Study
